Homocysteine-lowering vitamin B supplements do not improve cognitive performance in healthy older adults after two years.

Homocysteine-lowering vitamin B supplements do not improve cognitive performance in healthy older adults after two years.

Bibliographic Details
Main Author:	Clarke, R
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
by: Clarke, R, et al.
Published: (2000)

Homocysteine, B vitamins, and cognitive impairment
by: Smith, A, et al.
Published: (2016)

Homocysteine, B vitamins, and cognitive deficit in the elderly.
by: Smith, A
Published: (2002)

Predicting cognitive decline in healthy older adults.
by: De Jager, C, et al.
Published: (2005)

Homocysteine, B vitamins, and the risk of dementia.
by: Clarke, R
Published: (2007)

Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials.
by: Clarke, R
Published: (2000)

Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals.
by: Clarke, R, et al.
Published: (2014)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
by: de Jager, C, et al.
Published: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
by: De Jager, C, et al.
Published: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
by: De Jager, C, et al.
Published: (2012)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
by: Clarke, R
Published: (2011)

Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom.
by: Dangour, A, et al.
Published: (2008)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
by: Clarke, R, et al.
Published: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
by: Clarke, R, et al.
Published: (2011)

Low vitamin B-12 status and risk of cognitive decline in older adults.
by: Clarke, R, et al.
Published: (2007)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
by: Clarke, R, et al.
Published: (2005)

Associations between mobility, cognition and brain structure in healthy older adults
by: Demnitz, N, et al.
Published: (2017)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: Smith, A, et al.
Published: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: Smith, A, et al.
Published: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
by: Smith, A, et al.
Published: (2010)

Homocysteine, B vitamins, and cardiovascular disease
by: Refsum, H, et al.
Published: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
by: Refsum, H, et al.
Published: (2006)

Homocysteine-lowering trials for prevention of heart disease and stroke.
by: Clarke, R
Published: (2005)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
by: Clarke, R
Published: (2009)

Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
by: Brattstrom, L, et al.
Published: (1998)

Characterising the relationship between mobility, cognition and brain structure in healthy older adults
by: Demnitz, N
Published: (2018)

Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study.
by: van Oort, F, et al.
Published: (2003)

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease
by: Haynes, R, et al.
Published: (2012)

Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people.
by: Budge, M, et al.
Published: (2002)

Homocysteine lowering: any use in atherosclerosis?
by: Antoniades, C, et al.
Published: (2007)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
by: Clarke, R, et al.
Published: (1998)

Folic acid and vitamin B12 for prevention of cognitive decline in older people with depression
by: Clarke, R
Published: (2012)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
by: Clarke, R, et al.
Published: (2007)

Effects of cholesterol-lowering therapy and antioxidant vitamin supplementation on the risk of stroke
by: Collins, R, et al.
Published: (2002)

High-dose oral vitamin D supplementation and risk of falls in older women.
by: Prieto-Alhambra, D, et al.
Published: (2010)

A randomised controlled trial investigating the effect of vitamin B12 supplementation on neurological function in healthy older people: the Older People and Enhanced Neurological function (OPEN) study protocol [ISRCTN54195799].
by: Dangour, A, et al.
Published: (2011)

Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study.
by: Prins, N, et al.
Published: (2002)

Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial.
by: Eussen, S, et al.
Published: (2005)

Utility of TICS-M for the assessment of cognitive function in older adults.
by: de Jager, C, et al.
Published: (2003)

The associations of age, cardiovascular morbidity, and plasma homocysteine with brain atrophy in stroke-free, nondemented older adults.
by: Budge, M, et al.
Published: (2004)